Larvol Delta - Alzamend-Neuro-Announces-Full-Data-Set-from-Phase-IIA-Multiple-Ascending-Dose-Clinical-Trial-for-AL001-Treatment-of-Dementia-Related-to-Alzheimers

LISPRO (lithium/proline/salicylate) - Alzamend Neuro

https://www.businesswire.com/news/home/20241016892109/en/Alzamend-Neuro-Announces-Full-Data-Set-from-Phase-IIA-Multiple-Ascending-Dose-Clinical-Trial-for-AL001-Treatment-of-Dementia-Related-to-Alzheimer%E2%80%99s

Oct 16, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next